Jason S. Knight/X
Jul 31, 2025, 16:43
Jason S Knight: Antiphospholipid Syndrome Review
Jason S Knight, Professor at University of Michigan Medical School, shared a post on X:
“ICYMI, our review article about antiphospholipid syndrome in ACR Journals is now nicely formatted (and remains free)
Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities․”
Title: Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities
Authors: Thalia G. Newman, Jason S. Knight
Read the full article here.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency